| Update on psoriasis immunopathogenesis and targeted immunotherapy SK Mahil, F Capon, JN Barker Seminars in immunopathology 38, 11-27, 2016 | 297 | 2016 |
| EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris–Part 1: treatment and monitoring recommendations A Nast, C Smith, PI Spuls, G Avila Valle, Z Bata‐Csörgö, H Boonen, ... Journal of the European Academy of Dermatology and Venereology 34 (11), 2461 …, 2020 | 266* | 2020 |
| Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study SK Mahil, N Dand, KJ Mason, ZZN Yiu, T Tsakok, F Meynell, B Coker, ... Journal of allergy and clinical immunology 147 (1), 60-71, 2021 | 172 | 2021 |
| British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update CH Smith, ZZN Yiu, T Bale, AD Burden, LC Coates, W Edwards, ... British Journal of Dermatology 183 (4), 628-637, 2020 | 167 | 2020 |
| Psoriasis: a brief overview A Raharja, SK Mahil, JN Barker Clinical Medicine 21 (3), 170, 2021 | 166 | 2021 |
| The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study SK Mahil, K Bechman, A Raharja, C Domingo-Vila, D Baudry, MA Brown, ... The Lancet Rheumatology 3 (9), e627-e637, 2021 | 165 | 2021 |
| AP1S3 mutations cause skin autoinflammation by disrupting keratinocyte autophagy and up-regulating IL-36 production SK Mahil, S Twelves, K Farkas, N Setta-Kaffetzi, AD Burden, JE Gach, ... Journal of Investigative Dermatology 136 (11), 2251-2259, 2016 | 152 | 2016 |
| An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target SK Mahil, M Catapano, P Di Meglio, N Dand, H Ahlfors, IM Carr, CH Smith, ... Science translational medicine 9 (411), eaan2514, 2017 | 148 | 2017 |
| Genetics of psoriasis SK Mahil, F Capon, JN Barker Dermatologic clinics 33 (1), 1-11, 2015 | 137 | 2015 |
| Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis vulgaris DM Berki, L Liu, SE Choon, AD Burden, CEM Griffiths, AA Navarini, ... Journal of Investigative Dermatology 135 (12), 2964-2970, 2015 | 127 | 2015 |
| Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and … SK Mahil, N Wilson, N Dand, NJ Reynolds, CEM Griffiths, R Emsley, ... British Journal of Dermatology 182 (5), 1158-1166, 2020 | 117 | 2020 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 110 | 2021 |
| Psoriasis and genetics N Dand, SK Mahil, F Capon, CH Smith, MA Simpson, JN Barker Acta Derm Venereol 100 (3), 00015555-3384, 2020 | 107 | 2020 |
| Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single‐centre, cohort study SK Mahil, Z Arkir, G Richards, CM Lewis, JN Barker, CH Smith British Journal of Dermatology 169 (2), 306-313, 2013 | 85 | 2013 |
| IL-36 promotes systemic IFN-I responses in severe forms of psoriasis M Catapano, M Vergnano, M Romano, SK Mahil, SE Choon, AD Burden, ... Journal of Investigative Dermatology 140 (4), 816-826. e3, 2020 | 77 | 2020 |
| Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A critically appraised topic SK Mahil, SM McSweeney, E Kloczko, B McGowan, JN Barker, CH Smith British Journal of Dermatology 181 (5), 946-953, 2019 | 77 | 2019 |
| Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study SK Mahil, K Bechman, A Raharja, C Domingo-Vila, D Baudry, MA Brown, ... The Lancet Rheumatology 4 (1), e42-e52, 2022 | 76 | 2022 |
| Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta‐analysis SK Mahil, MC Ezejimofor, LS Exton, L Manounah, AD Burden, LC Coates, ... British Journal of Dermatology 183 (4), 638-649, 2020 | 73 | 2020 |
| Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease M Vergnano, M Mockenhaupt, N Benzian-Olsson, M Paulmann, K Grys, ... The American Journal of Human Genetics 107 (3), 539-543, 2020 | 53 | 2020 |
| Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling N Dand, S Mucha, LC Tsoi, SK Mahil, PE Stuart, A Arnold, H Baurecht, ... Human molecular genetics 26 (21), 4301-4313, 2017 | 52 | 2017 |
